This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Doctolib's French antitrust sanction sends warning on acquisition strategies

By Jean Comte ( November 6, 2025, 17:17 GMT | Comment) -- A sanction against Doctolib is the French competition watchdog's first time penalizing an acquisition as a dominance abuse, since the EU Court of Justice confirmed the possibility in its Towercast ruling. French enforcers warned the fine could be higher for future offenders, which could also face their deals being unpicked. But the regulator's president, Benoit Coeuré, acknowledged that more legal certainty would come with call-in powers that he hopes to gain soon.Dominant French companies have been warned: Buying a small rival to smother competition can lead to an antitrust sanction. Even if the deal is seven years old....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login